{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:46:18Z","timestamp":1790109978551,"version":"4.0.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11102-023-01301-y","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T09:02:37Z","timestamp":1677920557000},"page":"263-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2912-5355","authenticated-orcid":false,"given":"Anat","family":"Ben-Shlomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"issue":"6","key":"1301_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41568-018-0006-7","volume":"18","author":"S Maman","year":"2018","unstructured":"Maman S, Witz IP (2018) A history of exploring cancer in context. Nat Rev Cancer 18(6):359\u2013376. https:\/\/doi.org\/10.1038\/s41568-018-0006-7","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1301_CR2","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1002\/ijc.32343","volume":"145","author":"L Laplane","year":"2019","unstructured":"Laplane L, Duluc D, Bikfalvi A, Larmonier N, Pradeu T (2019) Beyond the tumour microenvironment. Int J Cancer 145(10):2611\u20132618. https:\/\/doi.org\/10.1002\/ijc.32343","journal-title":"Int J Cancer"},{"key":"1301_CR3","doi-asserted-by":"publisher","unstructured":"Ilie MD, Vasiljevic A, Raverot G, Bertolino P (2019) The Microenvironment of Pituitary Tumors-Biological and therapeutic implications. Cancers (Basel) 11(10). https:\/\/doi.org\/10.3390\/cancers11101605","DOI":"10.3390\/cancers11101605"},{"key":"1301_CR4","doi-asserted-by":"publisher","first-page":"785050","DOI":"10.3389\/fendo.2021.785050","volume":"12","author":"C Han","year":"2021","unstructured":"Han C, Lin S, Lu X, Xue L, Wu ZB (2021) Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma researches. Front Endocrinol (Lausanne) 12:785050. https:\/\/doi.org\/10.3389\/fendo.2021.785050","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1301_CR5","doi-asserted-by":"publisher","first-page":"608422","DOI":"10.3389\/fendo.2020.608422","volume":"11","author":"C Dai","year":"2020","unstructured":"Dai C, Liang S, Sun B, Kang J (2020) The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas. Front Endocrinol (Lausanne) 11:608422. https:\/\/doi.org\/10.3389\/fendo.2020.608422","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1301_CR6","doi-asserted-by":"publisher","unstructured":"Papait A, Romoli J, Stefani FR, Chiodelli P, Montresor MC, Agoni L et al (2022) Fight the Cancer, hit the CAF! Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14153570. 15","DOI":"10.3390\/cancers14153570"},{"issue":"4","key":"1301_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1055\/s-0043-119636","volume":"126","author":"L Lv","year":"2018","unstructured":"Lv L, Zhang S, Hu Y, Zhou P, Gao L, Wang M et al (2018) Invasive Pituitary Adenoma-Derived Tumor-Associated fibroblasts promote Tumor Progression both in Vitro and in vivo. Exp Clin Endocrinol Diabetes 126(4):213\u2013221. https:\/\/doi.org\/10.1055\/s-0043-119636","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"1301_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1530\/ERC-19-0327","volume":"26","author":"P Marques","year":"2019","unstructured":"Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Awad S et al (2019) Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness. Endocr Relat Cancer 26(12):853\u2013865. https:\/\/doi.org\/10.1530\/ERC-19-0327","journal-title":"Endocr Relat Cancer"},{"key":"1301_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mce.2014.12.024","volume":"402","author":"Z Li","year":"2015","unstructured":"Li Z, Liu Q, Li C, Zong X, Bai J, Wu Y et al (2015) The role of TGF-beta\/Smad signaling in dopamine agonist-resistant prolactinomas. Mol Cell Endocrinol 402:64\u201371. https:\/\/doi.org\/10.1016\/j.mce.2014.12.024","journal-title":"Mol Cell Endocrinol"},{"key":"1301_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainres.2018.07.024","volume":"1698","author":"B Hu","year":"2018","unstructured":"Hu B, Mao Z, Jiang X, He D, Wang Z, Wang X et al (2018) Role of TGF-beta1\/Smad3-mediated fibrosis in drug resistance mechanism of prolactinoma. Brain Res 1698:204\u2013212. https:\/\/doi.org\/10.1016\/j.brainres.2018.07.024","journal-title":"Brain Res"},{"key":"1301_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainresbull.2019.03.013","volume":"149","author":"B Hu","year":"2019","unstructured":"Hu B, Mao Z, Du Q, Jiang X, Wang Z, Xiao Z et al (2019) Mir-93-5p targets Smad7 to regulate the transforming growth factor-beta1\/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma. Brain Res Bull 149:21\u201331. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.03.013","journal-title":"Brain Res Bull"},{"issue":"3","key":"1301_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12020-015-0802-8","volume":"52","author":"HM Ozkaya","year":"2016","unstructured":"Ozkaya HM, Comunoglu N, Keskin FE, Oz B, Haliloglu OA, Tanriover N et al (2016) Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas. Endocrine 52(3):632\u2013640. https:\/\/doi.org\/10.1007\/s12020-015-0802-8","journal-title":"Endocrine"},{"issue":"7","key":"1301_CR13","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.7150\/jca.52937","volume":"12","author":"F Jian","year":"2021","unstructured":"Jian F, Sun Y, Sun Q, Zhang B, Bian L (2021) NEK2 regulates cellular proliferation and cabergoline sensitivity in pituitary adenomas. J Cancer 12(7):2083\u20132091. https:\/\/doi.org\/10.7150\/jca.52937","journal-title":"J Cancer"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-023-01301-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T09:24:00Z","timestamp":1688981040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-023-01301-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1007\/s11102-023-01301-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"7 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}